Stockscreener 앱 받기
65.49
0.34%
0.22
시간 외 거래:
65.65
0.16
+0.24%
전일 마감가:
$65.27
열려 있는:
$65.38
하루 거래량:
3.83M
Relative Volume:
0.61
시가총액:
$25.54B
수익:
$4.30B
순이익/손실:
$571.50M
주가수익비율:
45.85
EPS:
1.4285
순현금흐름:
$570.80M
1주 성능:
+3.18%
1개월 성능:
+10.48%
6개월 성능:
-23.62%
1년 성능:
-17.02%
1일 변동 폭
$65.15
$66.75
1주일 범위
$62.32
$66.75
52주 변동 폭
$54.11
$93.25
덱스컴 Stock (DXCM) Company Profile
명칭
Dexcom Inc
전화
(858) 200-0200
주소
6340 SEQUENCE DRIVE, SAN DIEGO, CA
DXCM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
65.49 | 25.45B | 4.30B | 571.50M | 570.80M | 1.4285 |
|
ABT
Abbott Laboratories
|
125.08 | 218.05B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.52 | 144.86B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
364.02 | 139.34B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.36 | 130.75B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
86.19 | 49.78B | 5.88B | 1.34B | 799.60M | 2.3489 |
덱스컴 Stock (DXCM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-11-25 | 개시 | Evercore ISI | In-line |
| 2025-10-21 | 재개 | Stifel | Buy |
| 2025-09-08 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2025-08-21 | 개시 | Argus | Buy |
| 2025-06-16 | 개시 | Truist | Buy |
| 2025-05-30 | 개시 | Goldman | Buy |
| 2025-04-10 | 개시 | Mizuho | Outperform |
| 2025-02-03 | 업그레이드 | Redburn Atlantic | Neutral → Buy |
| 2025-01-16 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-07-26 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-07-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-05-30 | 개시 | Redburn Atlantic | Neutral |
| 2024-03-12 | 개시 | RBC Capital Mkts | Outperform |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-04-17 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-03-29 | 개시 | UBS | Buy |
| 2023-01-26 | 개시 | Wolfe Research | Outperform |
| 2022-10-18 | 개시 | Barclays | Equal Weight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-15 | 개시 | Bernstein | Outperform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-03 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-01-19 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-01-07 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2021-10-18 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-07-21 | 재개 | Cowen | Outperform |
| 2021-05-28 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2021-01-06 | 업그레이드 | UBS | Neutral → Buy |
| 2020-10-02 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2020-05-27 | 재확인 | Piper Sandler | Overweight |
| 2020-05-14 | 개시 | Wells Fargo | Equal Weight |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2019-11-07 | 재확인 | Canaccord Genuity | Buy |
| 2019-11-07 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2019-10-23 | 개시 | Stifel | Buy |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-10-19 | 업그레이드 | Goldman | Sell → Neutral |
| 2018-09-12 | 업그레이드 | Northland Capital | Under Perform → Market Perform |
| 2018-08-02 | 재확인 | Canaccord Genuity | Buy |
| 2018-07-02 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2018-06-08 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-05-11 | 개시 | BofA/Merrill | Buy |
| 2018-05-03 | 재확인 | Canaccord Genuity | Buy |
| 2018-04-04 | 개시 | Goldman | Sell |
| 2018-04-04 | 개시 | Guggenheim | Neutral |
| 2018-03-23 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2018-01-04 | 다운그레이드 | Northland Capital | Market Perform → Under Perform |
| 2017-09-28 | 재확인 | Wedbush | Outperform |
모두보기
덱스컴 주식(DXCM)의 최신 뉴스
HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PR Newswire
Lowey Dannenberg Notifies DexCom, Inc. (“DexCom” or the - GlobeNewswire
Lowey Dannenberg Notifies DexCom, Inc. (“DexCom” or the “Company”) (NASDAQ: DXCM) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm - GlobeNewswire Inc.
SueWallSt Podcast Series Launches With Focus on DexCom, Inc. (DXCM) Fraud Allegations - ACCESS Newswire
DXCM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
DexCom, Inc. $DXCM Shares Acquired by Marshall Wace LLP - MarketBeat
How DexCom Inc. (DC4) stock trades after rate cutsJuly 2025 Analyst Calls & Advanced Technical Analysis Signals - Newser
Baird Financial Group Inc. Sells 49,243 Shares of DexCom, Inc. $DXCM - Defense World
Is DexCom Inc. (DC4) stock cheap by valuation metricsQuarterly Profit Review & Daily Oversold Bounce Ideas - Newser
Bragar Eagel & Squire, P.C. Urges DexCom and Wildermuth - GlobeNewswire
Key facts: Class Action Filed Against DexCom; Company Launches Academy - TradingView
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
DexCom, Inc. Sued for Securities Law ViolationsInvestors Should Contact The Gross Law Firm Before December 26, 2025 to Discuss Your RightsDXCM - PR Newswire
Listening to healthcare professionals: Dexcom launches new education offering, Dexcom Academy - marketscreener.com
Listening to Healthcare Professionals: Dexcom Launches New Education Offering, Dexcom Academy - Eagle-Tribune
Investors SueWallSt as DexCom, Inc. Faces Securities Fraud Allegations - Nasdaq
The Gross Law Firm Notifies Shareholders of DexCom, - GlobeNewswire
DEXCOM, INC. (NASDAQ: DXCM) SHAREHOLDER ALERT Bernstein - GlobeNewswire
DXCM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Isthmus Partners LLC Takes $14.61 Million Position in DexCom, Inc. $DXCM - MarketBeat
Is DexCom Stock Underperforming the S&P 500? - Barchart.com
Groupe la Francaise Increases Stock Holdings in DexCom, Inc. $DXCM - MarketBeat
Fisher Asset Management LLC Decreases Holdings in DexCom, Inc. $DXCM - Defense World
How DexCom Inc. (DC4) stock trades after earnings2025 Earnings Surprises & High Return Stock Watch Alerts - Newser
DXCM DEADLINE: DexCom, Inc. Investors Encouraged to Contact Kirby McInerney LLP Before Looming Deadline in Lawsuit - ACCESS Newswire
Morgan Stanley Upgrades DexCom (DXCM) - Nasdaq
DXCM DEADLINE: ROSEN, TOP RANKED INVESTOR COUNSEL, - GlobeNewswire
DexCom (DXCM): Morgan Stanley Upgrades Rating to Overweight and - GuruFocus
DexCom Stock Upgraded. How the Glucose Monitor Maker Is ‘Turning a Corner.’ - Barron's
DXCM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
DexCom (DXCM) Upgraded by Morgan Stanley with Increased Price Ta - GuruFocus
DexCom upgraded at Morgan Stanley on sorting out operational issues - Seeking Alpha
DexCom, Inc. (DXCM) Investors: December 26, 2025 Filing Deadline in Securities Class ActionContact Lieff Cabraser - ACCESS Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom LawsuitDXCM - PR Newswire
XTX Topco Ltd Lowers Stock Position in DexCom, Inc. $DXCM - MarketBeat
Analyst recommendations: Albemarle, Dexcom, T-Mobile, Alphabet, Micron… - marketscreener.com
Morgan Stanley Upgrades DexCom to Overweight From Equalweight, Adjusts PT to $75 From $63 - marketscreener.com
Advisors Asset Management Inc. Sells 1,259 Shares of DexCom, Inc. $DXCM - Defense World
DexCom, Inc. Sued for Securities Law Violations – Investors - GlobeNewswire
DexCom, Inc. Class Action: The Gross Law Firm Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 26, 2025DXCM - PR Newswire
Vinva Investment Management Ltd Buys Shares of 6,994 DexCom, Inc. $DXCM - MarketBeat
Mackenzie Financial Corp Trims Stake in DexCom, Inc. $DXCM - MarketBeat
State Board of Administration of Florida Retirement System Has $33.95 Million Position in DexCom, Inc. $DXCM - MarketBeat
Global Retirement Partners LLC Takes $472,000 Position in DexCom, Inc. $DXCM - MarketBeat
DXCM Deadline: DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit - Morningstar
Levi & Korsinsky Urges DexCom, Inc. (DXCM) Shareholders to Act Before Lead Plaintiff Deadline December 26, 2025 - ACCESS Newswire
DXCM CLASS ACTION FILED: Kessler Topaz Meltzer & Check, LLP - GlobeNewswire
DXCM Shareholders Have Opportunity to Lead DexCom, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
DexCom, Inc. $DXCM Stock Position Raised by Level Four Advisory Services LLC - MarketBeat
2025-11-29 | Securities Fraud Class Action Filed Against DexCom, Inc. (DXCM)Levi & Korsinsky Reminds Investors of December 26, 2025 | NDAQ:DXCM | Press Release - Stockhouse
DXCM Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against DexCom, Inc. (DXCM) - PR Newswire
덱스컴 (DXCM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.46%
3.78%
자본화:
|
볼륨(24시간):